Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in Am J Geriatr Psychiatry

Retrieve available abstracts of 77 articles:
HTML format



Single Articles


    March 2021
  1. GOVEAS JS
    Commentary on "Cannabinoids for Agitation in Alzheimer's Disease".
    Am J Geriatr Psychiatry. 2021 Mar 19. pii: S1064-7481(21)00262.
    PubMed    


    February 2021
  2. CHAN CK, Sieber FE, Blennow K, Inouye SK, et al
    Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients.
    Am J Geriatr Psychiatry. 2021 Feb 4. pii: S1064-7481(21)00166.
    PubMed     Abstract available


    January 2021
  3. OUTEN JD, Burhanullah MH, Vandrey R, Amjad H, et al
    Cannabinoids for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2021 Jan 27. pii: S1064-7481(21)00030.
    PubMed     Abstract available


  4. KIM D, Wang R, Kiss A, Bronskill SE, et al
    Depression and Increased Risk of Alzheimer's Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors.
    Am J Geriatr Psychiatry. 2021 Jan 6. pii: S1064-7481(20)30600.
    PubMed     Abstract available


  5. ALEXOPOULOS GS
    Neurobiological Targets of Apathy Can Guide Treatment Development.
    Am J Geriatr Psychiatry. 2021;29:63-65.
    PubMed    


    November 2020
  6. GATCHEL JR
    Late-Life Depression and Alzheimer's Disease Pathology: An Ounce of Prevention, a Pound of Cure.
    Am J Geriatr Psychiatry. 2020 Nov 28. pii: S1064-7481(20)30559.
    PubMed    


    September 2020
  7. CHU J, Benjenk I, Chen J
    Incremental Health Care Expenditures of the Spouses of Older Adults With Alzheimer's Diseases and Related Dementias (ADRD).
    Am J Geriatr Psychiatry. 2020 Sep 30. pii: S1064-7481(20)30502.
    PubMed     Abstract available


  8. WEINBERG MS, Patrick RE, Schwab NA, Owoyemi P, et al
    Clinical Trials and Tribulations in the COVID-19 Era.
    Am J Geriatr Psychiatry. 2020;28:913-920.
    PubMed     Abstract available


    August 2020
  9. HAMILTON CA, Matthews FE, Donaghy PC, Taylor JP, et al
    Cognitive Decline in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease: A Prospective Cohort Study.
    Am J Geriatr Psychiatry. 2020 Aug 8. pii: S1064-7481(20)30437.
    PubMed     Abstract available


    July 2020
  10. ORSO B, Mattei C, Arnaldi D, Massa F, et al
    Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia.
    Am J Geriatr Psychiatry. 2020;28:755-763.
    PubMed     Abstract available


    May 2020
  11. LANCTOT KL, Scherer RW, Li A, Vieira D, et al
    Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
    Am J Geriatr Psychiatry. 2020 May 27. pii: S1064-7481(20)30349.
    PubMed     Abstract available


  12. VAN DYCK CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, et al
    Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
    Am J Geriatr Psychiatry. 2020 May 5. pii: S1064-7481(20)30327.
    PubMed     Abstract available


  13. KEMP EC, Ebner MK, Ramanan S, Godek TA, et al
    Statin Use and Risk of Cognitive Decline in the ADNI Cohort.
    Am J Geriatr Psychiatry. 2020;28:507-517.
    PubMed     Abstract available


    April 2020
  14. ISAIA G, Marinello R, Tibaldi V, Tamone C, et al
    Atypical Presentation of Covid-19 in an Older Adult With Severe Alzheimer Disease.
    Am J Geriatr Psychiatry. 2020 Apr 22. pii: S1064-7481(20)30319.
    PubMed    


  15. BROWN EE, Kumar S, Rajji TK, Pollock BG, et al
    Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2020 Apr 18. pii: S1064-7481(20)30294.
    PubMed     Abstract available


  16. BEAUDREAU SA, Schneider L
    Commentary on "The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum".
    Am J Geriatr Psychiatry. 2020 Apr 15. pii: S1064-7481(20)30291.
    PubMed    


  17. ALMEIDA OP, Ford AH
    Are We Getting Better at Managing Agitation in Dementia?
    Am J Geriatr Psychiatry. 2020;28:401-403.
    PubMed    


    March 2020
  18. CHEN CL, Liang CK, Yin CH, Lin YT, et al
    Corrigendum to 'Effects of Socioeconomic Status on Alzheimer Disease Mortality in Taiwan' [The American Journal of Geriatric Psychiatry 28 (2020) 205-216].
    Am J Geriatr Psychiatry. 2020 Mar 17. pii: S1064-7481(20)30256.
    PubMed    


    February 2020
  19. BANNING LCP, Ramakers IHGB, Kohler S, Bron EE, et al
    The Association Between Biomarkers and Neuropsychiatric Symptoms Across the Alzheimer's Disease Spectrum.
    Am J Geriatr Psychiatry. 2020 Feb 19. pii: S1064-7481(20)30025.
    PubMed     Abstract available


  20. WEI S, Gao L, Jiang Y, Shang S, et al
    Apolipoprotein E epsilon4 Allele is Associated With Plasma Amyloid Beta and Amyloid Beta Transporter Levels: A Cross-sectional Study in a Rural Area of Xi'an, China.
    Am J Geriatr Psychiatry. 2020;28:194-204.
    PubMed     Abstract available


    January 2020
  21. SWERDLOW NR
    Commentary: Lessons Learned From Animal Models for Schizophrenia.
    Am J Geriatr Psychiatry. 2020;28:20-22.
    PubMed    


  22. TAN ECK, Johnell K, Bell JS, Garcia-Ptacek S, et al
    Do Acetylcholinesterase Inhibitors Prevent or Delay Psychotropic Prescribing in People With Dementia? Analyses of the Swedish Dementia Registry.
    Am J Geriatr Psychiatry. 2020;28:108-117.
    PubMed     Abstract available


  23. BURHANULLAH MH, Tschanz JT, Peters ME, Leoutsakos JM, et al
    Neuropsychiatric Symptoms as Risk Factors for Cognitive Decline in Clinically Normal Older Adults: The Cache County Study.
    Am J Geriatr Psychiatry. 2020;28:64-71.
    PubMed     Abstract available


    October 2019
  24. FORESTER BP, Rahman AT, Harper DG, Petrides G, et al
    Evolving Evidence for the Efficacy and Safety of ECT for Agitation in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Oct 24. pii: S1064-7481(19)30548.
    PubMed    


  25. GROSSBERG GT, Kohegyi E, Mergel V, Josiassen MK, et al
    Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.
    Am J Geriatr Psychiatry. 2019 Oct 1. pii: S1064-7481(19)30521.
    PubMed     Abstract available


    August 2019
  26. RANDOLPH C
    The Utility of Episodic Memory Cut-Off Scores for Inclusion in Clinical Trials for Early Symptomatic Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Aug 19. pii: S1064-7481(19)30475.
    PubMed     Abstract available


  27. NOVAK P, Chu J, Ali MM, Chen J, et al
    Racial and Ethnic Disparities in Serious Psychological Distress Among Those With Alzheimer's Disease and Related Dementias.
    Am J Geriatr Psychiatry. 2019 Aug 15. pii: S1064-7481(19)30473.
    PubMed     Abstract available


  28. CHAPMAN BP, Phillips C
    Financial Risk Aversion and Incipient Dementia.
    Am J Geriatr Psychiatry. 2019;27:862-864.
    PubMed    


    July 2019
  29. CHANG MC, Lee AY, Kwak S, Kwak SG, et al
    Effect of Resistance Exercise on Depression in Mild Alzheimer Disease Patients With Sarcopenia.
    Am J Geriatr Psychiatry. 2019 Jul 27. pii: S1064-7481(19)30458.
    PubMed    


  30. PRASAD KM
    Digging Deeper Into Delusion Circuitry in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 Jul 3. pii: S1064-7481(19)30425.
    PubMed    


    June 2019
  31. CHEN NC, Liang CK, Yin CH, Lin YT, et al
    Effects of Socioeconomic Status on Alzheimer Disease Mortality in Taiwan.
    Am J Geriatr Psychiatry. 2019 Jun 24. pii: S1064-7481(19)30417.
    PubMed     Abstract available


  32. VYAS CM, Okereke OI
    Vitamin D and Psychosis in Alzheimer Disease: New Insights From Pharmacogenomics Research.
    Am J Geriatr Psychiatry. 2019 Jun 4. pii: S1064-7481(19)30392.
    PubMed    


    May 2019
  33. POLLOCK BG
    Commentary on "When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram".
    Am J Geriatr Psychiatry. 2019 May 27. pii: S1064-7481(19)30387.
    PubMed    


  34. ROSENBERG PB, Outen M S JD, Amjad M D M P H H, Burhanullah M D MH, et al
    Tetrahydrocannabinol Has Potential for Treating Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 24. pii: S1064-7481(19)30370.
    PubMed    


  35. PARADISE DM
    Commentary on: Mechanisms Linking White Matter Lesions, Tract Integrity and Depression in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 17. pii: S1064-7481(19)30365.
    PubMed    


  36. KRIVINKO JM, Koppel J, Savonenko A, Sweet RA, et al
    Animal Models of Psychosis in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 May 17. pii: S1064-7481(19)30364.
    PubMed     Abstract available


  37. AGA VM
    When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram.
    Am J Geriatr Psychiatry. 2019 May 10. pii: S1064-7481(19)30350.
    PubMed     Abstract available


  38. HERRMANN N, Ruthirakuhan M, Gallagher D, Verhoeff NPLG, et al
    Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease.
    Am J Geriatr Psychiatry. 2019 May 8. pii: S1064-7481(19)30355.
    PubMed     Abstract available


    April 2019
  39. YATAWARA C, Lee D, Ng KP, Chander R, et al
    Mechanisms Linking White Matter Lesions, Tract Integrity, and Depression in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2019 Apr 18. pii: S1064-7481(19)30337.
    PubMed     Abstract available


  40. SCHULZ R
    The Future of Caregiver Efficacy Research: Commentary on "Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers".
    Am J Geriatr Psychiatry. 2019 Apr 10. pii: S1064-7481(19)30334.
    PubMed    


  41. QIAN W, Fischer CE, Churchill NW, Kumar S, et al
    Delusions in Alzheimer Disease are Associated With Decreased Default Mode Network Functional Connectivity.
    Am J Geriatr Psychiatry. 2019 Apr 3. pii: S1064-7481(19)30331.
    PubMed     Abstract available


  42. VERMA M
    Reliably Assessing Language Function in Dementia in the 21st Century.
    Am J Geriatr Psychiatry. 2019;27:378-380.
    PubMed    


  43. STARKSTEIN S, Hayhow B
    Apathy in Dementia: Time to StandUp.
    Am J Geriatr Psychiatry. 2019;27:406-407.
    PubMed    


    March 2019
  44. WANG L, Ying J, Fan P, Weamer EA, et al
    Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.
    Am J Geriatr Psychiatry. 2019 Mar 27. pii: S1064-7481(19)30321.
    PubMed     Abstract available


  45. CHENG ST, Chan WC, Lam LCW
    Long-Term Outcomes of the Benefit-Finding Group Intervention for Alzheimer Family Caregivers: A Cluster-Randomized Double-Blind Controlled Trial.
    Am J Geriatr Psychiatry. 2019 Mar 26. pii: S1064-7481(19)30305.
    PubMed     Abstract available


  46. PATRICK RE, Hobbs K, Mathias L, Harper DG, et al
    The Limitations of Using Cognitive Cutoff Scores for Enrollment in Alzheimer Trials.
    Am J Geriatr Psychiatry. 2019 Mar 1. pii: S1064-7481(19)30275.
    PubMed    


  47. FUJISHIRO H
    Late-Life Depression and Lewy Body Disease.
    Am J Geriatr Psychiatry. 2019;27:287-289.
    PubMed    


    February 2019
  48. WILSON RS, Yu L, Schneider JA, Bennett DA, et al
    Risk Aversion and Alzheimer Disease in Old Age.
    Am J Geriatr Psychiatry. 2019 Feb 21. pii: S1064-7481(19)30253.
    PubMed     Abstract available


  49. RUTHIRAKUHAN M, Herrmann N, Vieira D, Gallagher D, et al
    The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment.
    Am J Geriatr Psychiatry. 2019 Feb 7. pii: S1064-7481(19)30242.
    PubMed     Abstract available


    January 2019
  50. PRASAD KM
    Delusions in Alzheimer Disease: What Researchers Should Not Forget.
    Am J Geriatr Psychiatry. 2019 Jan 9. pii: S1064-7481(19)30008.
    PubMed    


    December 2018
  51. ZHU CW, Grossman HT, Sano M
    Why Do They Just Sit? Apathy as a Core Symptom of Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Dec 17. pii: S1064-7481(18)30599.
    PubMed     Abstract available


    October 2018
  52. YU R, Topiwala A, Jacoby R, Fazel S, et al
    Aggressive Behaviors in Alzheimer Disease and Mild Cognitive Impairment: Systematic Review and Meta-Analysis.
    Am J Geriatr Psychiatry. 2018 Oct 19. pii: S1064-7481(18)30529.
    PubMed     Abstract available


  53. QIAN W, Schweizer TA, Churchill NW, Millikin C, et al
    Gray Matter Changes Associated With the Development of Delusions in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Oct 2. pii: S1064-7481(18)30499.
    PubMed     Abstract available


    September 2018
  54. BOTT NT, Sheckter CC, Yang D, Peters S, et al
    Systems Delivery Innovation for Alzheimer Disease.
    Am J Geriatr Psychiatry. 2018 Sep 28. pii: S1064-7481(18)30494.
    PubMed     Abstract available


  55. LINCOLN KD, Chow TW, Gaines BF
    BrainWorks: A Comparative Effectiveness Trial to Examine Alzheimer's Disease Education for Community-Dwelling African Americans.
    Am J Geriatr Psychiatry. 2018 Sep 21. pii: S1064-7481(18)30487.
    PubMed     Abstract available


    June 2018
  56. DEVANAND DP, Pelton GH, D'Antonio K, Ciarleglio A, et al
    Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial.
    Am J Geriatr Psychiatry. 2018 Jun 28. pii: S1064-7481(18)30333.
    PubMed     Abstract available


    May 2018
  57. GALLAGHER D, Kiss A, Lanctot K, Herrmann N, et al
    Depression and Risk of Alzheimer's Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression.
    Am J Geriatr Psychiatry. 2018 May 9. pii: S1064-7481(18)30327.
    PubMed     Abstract available


  58. MUNRO CE, Donovan NJ, Amariglio RE, Papp KV, et al
    The Impact of Awareness of and Concern About Memory Performance on the Prediction of Progression From Mild Cognitive Impairment to Alzheimer Disease Dementia.
    Am J Geriatr Psychiatry. 2018 May 3. pii: S1064-7481(18)30323.
    PubMed     Abstract available


    April 2018
  59. WOODWARD MR, Hafeez MU, Qi Q, Riaz A, et al
    Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging.
    Am J Geriatr Psychiatry. 2018 Apr 19. pii: S1064-7481(18)30247.
    PubMed     Abstract available


    October 2017
  60. CONNORS MH, Ames D, Woodward M, Brodaty H, et al
    Psychosis and Clinical Outcomes in Alzheimer Disease: A Longitudinal Study.
    Am J Geriatr Psychiatry. 2017 Oct 20. pii: S1064-7481(17)30512.
    PubMed     Abstract available


    September 2017
  61. HUGHES TM, Lockhart SN, Smagula SF
    Blood Pressure's Role in Alzheimer Disease Pathology.
    Am J Geriatr Psychiatry. 2017 Sep 25. pii: S1064-7481(17)30468.
    PubMed    


    July 2017
  62. YOSHIDA K, Roberts R, Suzuki T, Lebowitz B, et al
    Lack of Early Improvement with Antipsychotics is a Marker for Subsequent Nonresponse in Behavioral and Psychological Symptoms of Dementia: Analysis of CATIE-AD Data.
    Am J Geriatr Psychiatry. 2017;25:708-716.
    PubMed     Abstract available


    June 2017
  63. ERSKINE D, Thomas AJ, Taylor JP, Savage MA, et al
    Neuronal Loss and Alpha-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.
    Am J Geriatr Psychiatry. 2017;25:595-604.
    PubMed     Abstract available


    April 2017
  64. KENNEDY RE, Cutter GR, Wang G, Schneider LS, et al
    Challenging Assumptions About African American Participation in Alzheimer Disease Trials.
    Am J Geriatr Psychiatry. 2017 Apr 25. pii: S1064-7481(17)30306.
    PubMed     Abstract available


    March 2017
  65. GEDA YE, Krell-Roesch J, Sambuchi N, Michel BF, et al
    Neuropsychiatric Symptoms and Neuroimaging Biomarkers in Alzheimer Disease: "Which is the Cart and Which is the Horse?"
    Am J Geriatr Psychiatry. 2017 Mar 16. pii: S1064-7481(17)30256.
    PubMed    


  66. ROSENBERG PB
    New Insights Into Brain Mechanisms Underlying Neuropsychiatric Symptoms in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Mar 8. pii: S1064-7481(17)30243.
    PubMed    


    February 2017
  67. MATIAS-GUIU JA, Cabrera-Martin MN, Valles-Salgado M, Perez-Perez A, et al
    Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints.
    Am J Geriatr Psychiatry. 2017 Feb 3. pii: S1064-7481(17)30194.
    PubMed     Abstract available


    January 2017
  68. WEISSBERGER GH, Melrose RJ, Narvaez TA, Harwood D, et al
    18F-Fluorodeoxyglucose Positron Emission Tomography Cortical Metabolic Activity Associated with Distinct Agitation Behaviors in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 31. pii: S1064-7481(17)30034.
    PubMed     Abstract available


  69. SMITH GS
    Molecular Imaging of the Nicotinic Cholinergic Receptor in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 5. pii: S1064-7481(17)30001.
    PubMed    


  70. SULTZER DL, Melrose RJ, Riskin-Jones H, Narvaez TA, et al
    Cholinergic Receptor Binding in Alzheimer Disease and Healthy Aging: Assessment In Vivo with Positron Emission Tomography Imaging.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30305.
    PubMed     Abstract available


  71. GATCHEL JR, Donovan NJ, Locascio JJ, Becker JA, et al
    Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2017 Jan 4. pii: S1064-7481(16)30348.
    PubMed     Abstract available


    November 2016
  72. KERNER NA, Roose SP, Pelton GH, Ciarleglio A, et al
    Association of Obstructive Sleep Apnea with Episodic Memory and Cerebral Microvascular Pathology: A Preliminary Study.
    Am J Geriatr Psychiatry. 2016 Nov 17. pii: S1064-7481(16)30303.
    PubMed     Abstract available


  73. REGAN B, Wells Y, Farrow M, O'Halloran P, et al
    MAXCOG-Maximizing Cognition: A Randomized Controlled Trial of the Efficacy of Goal-Oriented Cognitive Rehabilitation for People with Mild Cognitive Impairment and Early Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Nov 16. pii: S1064-7481(16)30302.
    PubMed     Abstract available


    October 2016
  74. LIN A, Brook J, Grill JD, Teng E, et al
    Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Oct 13. pii: S1064-7481(16)30273.
    PubMed     Abstract available


    August 2016
  75. ANTONSDOTTIR IM, Makino KM, Porsteinsson AP
    Dazed and Confused: Medical Cannabis in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Aug 31. pii: S1064-7481(16)30222.
    PubMed    


    July 2016
  76. ROY S, Ficarro S, Duberstein P, Chapman BP, et al
    Executive Function and Personality Predict Instrumental Activities of Daily Living in Alzheimer Disease.
    Am J Geriatr Psychiatry. 2016 Jul 4. pii: S1064-7481(16)30165.
    PubMed     Abstract available


    February 2016
  77. CHOI HJ, Seo EH, Yi D, Sohn BK, et al
    Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Am J Geriatr Psychiatry. 2016;24:144-53.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: